These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7414564)

  • 1. Effect of ticlopidine on human platelet responsiveness ex vivo: comparison with aspirin.
    Nunn B; Lindsay R
    Thromb Res; 1980 Jun; 18(6):807-813. PubMed ID: 7414564
    [No Abstract]   [Full Text] [Related]  

  • 2. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects.
    David JL; Monfort F; Herion F; Raskinet R
    Thromb Res; 1979 Jan; 14(1):35-49. PubMed ID: 425084
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro.
    Knudsen JB; Gormsen J
    Thromb Res; 1979; 16(5-6):663-71. PubMed ID: 524316
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study.
    Droste DW; Siemens HJ; Sonne M; Kaps M; Wagner T
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):591-4. PubMed ID: 8891887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticlopidine - an antiplatelet drug: effects in human volunteers.
    O'Brien JR; Etherington MD; Shuttleworth RD
    Thromb Res; 1978 Aug; 13(2):245-54. PubMed ID: 694843
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.
    Kirstein P; Jogestrand T; Johnsson H; Olsson AG
    Atherosclerosis; 1980 Aug; 36(4):471-80. PubMed ID: 7417366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets.
    Lips NP; Sixma JJ; Schiphorst ME
    Thromb Res; 1980 Jan 1-15; 17(1-2):19-27. PubMed ID: 7376129
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ticlopidine, a new platelet aggregation inhibitor in man.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    Clin Pharmacol Ther; 1975 Oct; 18(4):485-90. PubMed ID: 1100310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the platelet response to aspirin.
    Coppe D; Wessinger SJ; Ransil BJ; Harris W; Salzman E
    Thromb Res; 1981 Jul 1-15; 23(1-2):1-21. PubMed ID: 7302916
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo study of platelet aggregation in rats.
    Pinon JF
    J Pharmacol Methods; 1984 Sep; 12(2):79-84. PubMed ID: 6536819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
    Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
    J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.